, Tracking Stock Market Picks
Enter Symbol:
Discovery Laboratories, Inc. (DSCO) [hlAlert]

down 79.42 %

Discovery Laboratories, Inc. (DSCO) rated Buy with price target $5 by Stifel

Posted on: Tuesday,  Aug 19, 2014  12:00 AM ET by Stifel

Stifel rated Buy Discovery Laboratories, Inc. (NASDAQ: DSCO) on 08/19/2014, when the stock price was $1.75. Since
then, Discovery Laboratories, Inc. has lost 79.43% as of 01/25/2016's recent price of $0.36.
If you would have followed this Stifel's recommendation on DSCO, you would have lost 79.42% of your investment in 524 days.

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.

as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy